News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Imidomics and Wuxi Biologics Enter Strategic Collaboration for Advancing IMB1001 Antibody Development in Immune-mediated Inflammatory Conditions
Thursday, October 05, 2023IMIDomics Inc has recently announced a strategic partnership with WuXi Biologics a global Contract Research Development and Manufacturing Organization This collaboration aims to expedite the development and manufacturing of IMIDomics IMB
Shasqi's Plans for Expanding Ongoing Research Collaboration to Enhance Targeted Cancer Treatment
Thursday, October 05, 2023Shasqi Inc a clinicalstage biotechnology company with a mission to enhance the efficacy of cancer drugs through click chemistry has recently announced the expansion of its ongoing research collaboration with Johnson Johnson Enterprise Innovation Inc
Willow and Suanfarma Collaborate to Enhance Development of High-volume Anti-infective API
Wednesday, October 04, 2023Willow Biosciences Inc TSX WLLW OTCQB CANSF and SUANFARMA have jointly revealed a collaboration agreement to enhance cell line productivity for the production of a highvolume antiinfective active pharmaceutical ingredient API through precision fermen...
Alvotech and Kashiv Biosciences Establish Exclusive Licensing Agreement for Development and Commercialization of Proposed Xolair® (Omalizumab) Biosimilar
Wednesday, October 04, 2023Alvotech NASDAQ ALVO and Kashiv Biosciences LLC have recently announced an exclusive licensing agreement for AVT also known as ADL a potential biosimilar to Xolair omalizumab which is currently undergoing clinical development
IAMA Therapeutics and Evotec Establish Multi-phase, Strategic Provider Agreement
Tuesday, October 03, 2023IAMA Therapeutics a pharmaceutical company dedicated to developing innovative medicines for children affected by brain disorders has recently announced a strategic collaboration with Evotec a company specializing in integrated drug development soluti...
Melinta Therapeutics Announces Enhanced Reimbursement and Accessibility Options for REZZAYO™ (Rezafungin Injection)
Tuesday, October 03, 2023Melinta Therapeutics Melinta a company specializing in innovative therapies for acute and lifethreatening diseases has announced expanded reimbursement and access for their product
European Biopharma Sector Gears Up for Major Innovation Conference in Berlin
Tuesday, October 03, 2023
Breakthrough in mRNA Vaccine Development Announced by European Consortium
Tuesday, October 03, 2023
Alzamend Neuro Granted FDA Authorization for Phase IIA Clinical Trial of AL001, an Innovative Lithium-based Therapeutic, in Bipolar Disorder Patients
Monday, October 02, 2023Alzamend Neuro Inc Nasdaq ALZN has received a positive response from the US Food and Drug Administration FDA to proceed with their Phase IIA clinical study designated as ALBD for Bipolar Disorder type
Tradeup Acquisition Corp. And Estrella Biopharma, Inc. Announce the Successful Completion of Their Business Combination
Saturday, September 30, 2023Estrella Immunopharma Inc formerly known as TradeUP Acquisition Corp NASDAQ UPTD UPTDW UPTDU has successfully completed its merger with Estrella Biopharma Inc a preclinicalstage biopharmaceutical company specializing in Tcell therapies for blood canc...
